Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Targeting specific T cells may help treat alopecia areata.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

A patient with sickle cell trait and low vitamin D might have lupus, a rare combination that needs more attention.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Targeting CXCL10 may help treat alopecia areata.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

MS patients often have skin issues, so regular skin checks are important.

Etanercept may not prevent alopecia areata from coming back.